Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma

NCT02834546 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT02834546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02834546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Completed
Start date
July 25, 2017
Completion date
March 15, 2019
Enrollment
143 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc)